Contact
searchSearch
HMP Global
Login

April 2017

Interview
Christiana Care Health System Pioneers Clinical Pathways in the Tri-State Area
01/11/2019
Clinical pathways are not new, but their prominence has grown in recent years. An increased focus on value-based medical care1 has brought strategies that provide optimal treatment at a favorable cost to the...
Clinical pathways are not new, but their prominence has grown in recent years. An increased focus on value-based medical care1 has brought strategies that provide optimal treatment at a favorable cost to the...
...
01/11/2019
Journal of Clinical Pathways
From the Field
Establishment of Subspecialized Care in Hematologic Malignancies and a Hematopoietic Cell Transplant Program
04/11/2017
Belinda R. Avalos, MD
Abstract: The Levine Cancer Institute (LCI) of the Carolinas HealthCare System was established in Charlotte, NC, in 2010 as a primary through quaternary referral center. The Department of Hematologic Oncology and...
Abstract: The Levine Cancer Institute (LCI) of the Carolinas HealthCare System was established in Charlotte, NC, in 2010 as a primary through quaternary referral center. The Department of Hematologic Oncology and...
...
04/11/2017
Journal of Clinical Pathways
Research Reports
Length of Stay and Costs of COPD: Analysis of Hospitalized Patients Treated With Arformoterol or Nebulized Short-Acting Beta2-Agonists
04/11/2017
Tina Hunter, PhD; Scott B. Robinson, PhD, MD; Vamsi K. Bollu, PhD, MBA; Krithika Rajagopalan, PhD; Bernadette H. Johnson, MBA; Frank R. Ernst, PharmD, MS
Abstract: Hospitalization costs are substantial in chronic obstructive pulmonary disease (COPD). Little is known regarding the effect of long-acting beta2-agonists (LABAs) vs short-acting beta2-agonists (SABAs) on...
Abstract: Hospitalization costs are substantial in chronic obstructive pulmonary disease (COPD). Little is known regarding the effect of long-acting beta2-agonists (LABAs) vs short-acting beta2-agonists (SABAs) on...
...
04/11/2017
Journal of Clinical Pathways
Clinical Pathways GPS
Preparing for Take-Off: Readying Older Adults for Flight
04/11/2017
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD; Sevy Gambs, MBA, ALA, MSN-GR
Older adults are at risk for a host of potential medical issues while traveling, arising from cognitive impairments such as Alzheimer disease, dementia or psychiatric disorders, and chronic conditions such as...
Older adults are at risk for a host of potential medical issues while traveling, arising from cognitive impairments such as Alzheimer disease, dementia or psychiatric disorders, and chronic conditions such as...
...
04/11/2017
Journal of Clinical Pathways
Pharma Insights
The Clash: Treatment Advances and Value Measurements in Oncology
04/11/2017
Jason Shafrin, PhD; Larry Blandford, PharmD
Cancer has or will affect nearly every person at some point in their lives, either directly or indirectly. The fight against cancer is central to society; in recent years, treatment advances and prevention...
Cancer has or will affect nearly every person at some point in their lives, either directly or indirectly. The fight against cancer is central to society; in recent years, treatment advances and prevention...
...
04/11/2017
Journal of Clinical Pathways
Conference Coverage
Academy of Managed Care Pharmacy Annual Meeting
04/11/2017
The Academy of Managed Care Pharmacy (AMCP) is the leading professional organization for practitioners invested in the development and implementation of value-based care pathways within the managed care setting....
The Academy of Managed Care Pharmacy (AMCP) is the leading professional organization for practitioners invested in the development and implementation of value-based care pathways within the managed care setting....
The...
04/11/2017
Journal of Clinical Pathways
Conference Coverage
ASCO Quality Care Symposium
04/11/2017
Value-based medical care continues to gain traction in the oncology sphere, and tools for the developing, measuring, and implementing value measures in clinical practice are needed. The rapid introduction of new...
Value-based medical care continues to gain traction in the oncology sphere, and tools for the developing, measuring, and implementing value measures in clinical practice are needed. The rapid introduction of new...
...
04/11/2017
Journal of Clinical Pathways
Research in Review
Neurofeedback Reduces Nerve Damage From Chemotherapy in Cancer Survivors
04/11/2017
Chemotherapy-induced peripheral neuropathy (CIPN) may be significantly reduced by electroencephalogram (EEG) neurofeedback training, according to research published in Cancer (published online March 3, 2017;...
Chemotherapy-induced peripheral neuropathy (CIPN) may be significantly reduced by electroencephalogram (EEG) neurofeedback training, according to research published in Cancer (published online March 3, 2017;...
...
04/11/2017
Journal of Clinical Pathways
Research in Review
Leukemia Survival Outcomes Differ Between Sites of Care
04/11/2017
Sites of care may help explain survival differences between children and adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), according to research published...
Sites of care may help explain survival differences between children and adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), according to research published...
...
04/11/2017
Journal of Clinical Pathways
Research in Review
Novel Therapy Plus Gemcitabine Does Not Improve OS in Pancreatic Cancer
04/11/2017
A new tyrosine kinase inhibitor (TKI) in combination with gemcitabine does not improve overall survival (OS) any more than gemcitabine alone for patients with advanced pancreatic cancer, according to research...
A new tyrosine kinase inhibitor (TKI) in combination with gemcitabine does not improve overall survival (OS) any more than gemcitabine alone for patients with advanced pancreatic cancer, according to research...
A...
04/11/2017
Journal of Clinical Pathways
JCP July-Aug Cover 2025

Current Issue

August 2025
Volume 11
Issue 4
Current Issue
Issue Archive

Special Reports

Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
08/15/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
08/15/2025
Journal of Clinical Pathways
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
08/15/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
08/15/2025
Journal of Clinical Pathways
Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
06/12/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
06/12/2025
Journal of Clinical Pathways
Page 1
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
02/19/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
02/19/2025
Journal of Clinical Pathways
JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Robin T. Zon, MD, FACP, FASCO; Gordon Kuntz; Winston Wong, PharmD
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

Subscribe

Journal of Clinical Pathways Newsletter

Volume 3

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use